RATIONALE: This study is part of a larger, multi-method project to develop a questionnaire for identifying undiagnosed cases of chronic obstructive pulmonary disease (COPD) in primary care settings, with specific interest in the detection of patients with moderate to severe airway obstruction or risk of exacerbation. OBJECTIVES: To examine 3 existing datasets for insight into key features of COPD that could be useful in the identification of undiagnosed COPD. METHODS: Random forests analyses were applied to the following databases: COPD Foundation Peak Flow Study Cohort (N=5761), Burden of Obstructive Lung Disease (BOLD) Kentucky site (N=508), and COPDGene® (N=10,214). Four scenarios were examined to find the best, smallest sets of variables that distinguished cases and controls:(1) moderate to severe COPD (forced expiratory volume in 1 second [FEV1] <50% predicted) versus no COPD; (2) undiagnosed versus diagnosed COPD; (3) COPD with and without exacerbation history; and (4) clinically significant COPD (FEV1<60% predicted or history of acute exacerbation) versus all others. RESULTS: From 4 to 8 variables were able to differentiate cases from controls, with sensitivity ≥73 (range: 73-90) and specificity >68 (range: 68-93). Across scenarios, the best models included age, smoking status or history, symptoms (cough, wheeze, phlegm), general or breathing-related activity limitation, episodes of acute bronchitis, and/or missed work days and non-work activities due to breathing or health. CONCLUSIONS: Results provide insight into variables that should be considered during the development of candidate items for a new questionnaire to identify undiagnosed cases of clinically significant COPD.
RATIONALE: This study is part of a larger, multi-method project to develop a questionnaire for identifying undiagnosed cases of chronic obstructive pulmonary disease (COPD) in primary care settings, with specific interest in the detection of patients with moderate to severe airway obstruction or risk of exacerbation. OBJECTIVES: To examine 3 existing datasets for insight into key features of COPD that could be useful in the identification of undiagnosed COPD. METHODS: Random forests analyses were applied to the following databases: COPD Foundation Peak Flow Study Cohort (N=5761), Burden of Obstructive Lung Disease (BOLD) Kentucky site (N=508), and COPDGene® (N=10,214). Four scenarios were examined to find the best, smallest sets of variables that distinguished cases and controls:(1) moderate to severe COPD (forced expiratory volume in 1 second [FEV1] <50% predicted) versus no COPD; (2) undiagnosed versus diagnosed COPD; (3) COPD with and without exacerbation history; and (4) clinically significant COPD (FEV1<60% predicted or history of acute exacerbation) versus all others. RESULTS: From 4 to 8 variables were able to differentiate cases from controls, with sensitivity ≥73 (range: 73-90) and specificity >68 (range: 68-93). Across scenarios, the best models included age, smoking status or history, symptoms (cough, wheeze, phlegm), general or breathing-related activity limitation, episodes of acute bronchitis, and/or missed work days and non-work activities due to breathing or health. CONCLUSIONS: Results provide insight into variables that should be considered during the development of candidate items for a new questionnaire to identify undiagnosed cases of clinically significant COPD.
Entities:
Keywords:
COPD; case identification; chronic airways obstruction; data mining; primary care; random forests; screening
Authors: Natya Raghavan; Yuk-Miu Lam; Katherine A Webb; Jordan A Guenette; Naparat Amornputtisathaporn; Ramya Raghavan; Wan C Tan; Jean Bourbeau; Denis E O'Donnell Journal: COPD Date: 2012-03-12 Impact factor: 2.409
Authors: David B Price; David G Tinkelman; R J Halbert; Robert J Nordyke; Sharon Isonaka; Dmitry Nonikov; Elizabeth F Juniper; Daryl Freeman; Thomas Hausen; Mark L Levy; Anders Ostrem; Thys van der Molen; Constant P van Schayck Journal: Respiration Date: 2005-12-05 Impact factor: 3.580
Authors: Steven B Nelson; Lisa M LaVange; Yonghong Nie; John W Walsh; Paul L Enright; Fernando J Martinez; David M Mannino; Byron M Thomashow Journal: Chest Date: 2012-08 Impact factor: 9.410
Authors: Earl S Ford; David M Mannino; Anne G Wheaton; Wayne H Giles; Letitia Presley-Cantrell; Janet B Croft Journal: Chest Date: 2013-05 Impact factor: 9.410
Authors: Anamika Jithoo; Paul L Enright; Peter Burney; A Sonia Buist; Eric D Bateman; Wan C Tan; Michael Studnicka; Filip Mejza; Suzanne Gillespie; William M Vollmer Journal: Eur Respir J Date: 2012-06-27 Impact factor: 16.671
Authors: Meilan K Han; Min Gayles Kim; Russell Mardon; Phil Renner; Sean Sullivan; Gregory B Diette; Fernando J Martinez Journal: Chest Date: 2007-06-05 Impact factor: 9.410
Authors: Fernando J Martinez; Anastasia E Raczek; Frederic D Seifer; Craig S Conoscenti; Tammy G Curtice; Thomas D'Eletto; Claudia Cote; Clare Hawkins; Amy L Phillips Journal: COPD Date: 2008-04 Impact factor: 2.409
Authors: Matthew Moll; Dandi Qiao; Elizabeth A Regan; Gary M Hunninghake; Barry J Make; Ruth Tal-Singer; Michael J McGeachie; Peter J Castaldi; Raul San Jose Estepar; George R Washko; James M Wells; David LaFon; Matthew Strand; Russell P Bowler; MeiLan K Han; Jorgen Vestbo; Bartolome Celli; Peter Calverley; James Crapo; Edwin K Silverman; Brian D Hobbs; Michael H Cho Journal: Chest Date: 2020-04-27 Impact factor: 9.410
Authors: Fernando J Martinez; David Mannino; Nancy Kline Leidy; Karen G Malley; Elizabeth D Bacci; R Graham Barr; Russ P Bowler; MeiLan K Han; Julia F Houfek; Barry Make; Catherine A Meldrum; Stephen Rennard; Byron Thomashow; John Walsh; Barbara P Yawn Journal: Am J Respir Crit Care Med Date: 2017-03-15 Impact factor: 21.405
Authors: Wilson A Quezada; Beth A Whippo; Patricia A Jellen; Nancy K Leidy; David M Mannino; Katherine J Kim; MeiLan K Han; Julia F Houfek; Barry Make; Karen G Malley; Catherine A Meldrum; Stephen I Rennard; Barbara P Yawn; Fernando J Martinez; Byron M Thomashow Journal: Chest Date: 2017-04-14 Impact factor: 9.410